Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methods to Identify and Treat Severe Asthma Patients Project 1: GSNOR Phenotyping and GSNO Challenge

NCT03926741 is registered in ClinicalTrials.gov with James Reynolds as lead sponsor.

NCT NCT03926741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03926741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methods to Identify and Treat Severe Asthma Patients Project 1: GSNOR Phenotyping and GSNO Challenge
Lead sponsor
James Reynolds
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2019
Completion date
February 29, 2024
Enrollment
48 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

asthma